This company has been marked as potentially delisted and may not be actively trading. Enochian Biosciences (ENOB) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period The Secrets of Enochian: The Mysterious Language of AngelsNovember 15, 2024 | msn.comCITY WHISPERS: Dr No's firm in rebrand after Hindenburg disasterMarch 2, 2024 | msn.comRenovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock CrashesFebruary 13, 2024 | msn.comEastern & Oriental Bhd (ENOB)November 23, 2023 | investing.comAkoya Biosciences Stock (NASDAQ:AKYA), Analyst Ratings, Price Targets, PredictionsOctober 24, 2023 | benzinga.comRenovaro BioSciences (NASDAQ: RENB) CEO Releases Shareholder LetterOctober 3, 2023 | theglobeandmail.comRenovaro BioSciences (NASDAQ: RENB) Enters Definitive Agreement to Combine with Leading AI Tech GEDi CubeSeptember 30, 2023 | theglobeandmail.comRenovaro Biosciences Inc.September 11, 2023 | barrons.comRenovaro Biosciences Inc (RENB)September 3, 2023 | investing.comRenovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical OfficerAugust 21, 2023 | finance.yahoo.comRenovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against CancerAugust 10, 2023 | finance.yahoo.comAI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against CancerAugust 9, 2023 | finance.yahoo.com3 Doomed Biotech Stocks Destined for DisasterJuly 25, 2023 | finance.yahoo.comEnochian BioSciences, Inc.: Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingJune 23, 2023 | finanznachrichten.deEnochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder MeetingJune 23, 2023 | finance.yahoo.comEnochian BioSciences, Inc.: Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewJune 8, 2023 | finanznachrichten.deEnochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA ReviewJune 8, 2023 | finance.yahoo.comGrabar Law Office Investigates Claims on Behalf of Shareholders of Enochian Biosciences Inc. (ENOB)April 15, 2023 | markets.businessinsider.comEnochian BioSciences’ CEO Letter to ShareholdersApril 3, 2023 | finance.yahoo.comEnochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading ResearcherMarch 29, 2023 | finance.yahoo.comEnochian BioSciences, Inc.: Enochian BioSciences Achieves Full Compliance with NASDAQ Filing RequirementsMarch 13, 2023 | finanznachrichten.deEnochian BioSciences regains Nasdaq compliance by filing pending reportsMarch 13, 2023 | msn.comEnochian BioSciences Achieves Full Compliance with NASDAQ Filing RequirementsMarch 13, 2023 | finance.yahoo.comEnochian gets Nasdaq listing deficiency notice for not filing 10-QFebruary 23, 2023 | msn.comEnochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022February 23, 2023 | finance.yahoo.comENOB.O - | Stock Price & Latest News | ReutersJanuary 19, 2023 | reuters.comEnochian gets Nasdaq notice for delaying crucial filingsNovember 30, 2022 | seekingalpha.comEnochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022November 30, 2022 | finance.yahoo.comBiotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating DataOctober 24, 2022 | finance.yahoo.comEnochian BioSciences Forges Ahead With Focused Approach, Promising FutureOctober 24, 2022 | finance.yahoo.comEnochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-KOctober 21, 2022 | finance.yahoo.comEnochian BioSciences, Inc.: Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology PlatformOctober 19, 2022 | finanznachrichten.deEnochian BioSciences Awarded U.S. Patent For Its Promising Oncology PlatformOctober 17, 2022 | finance.yahoo.comEnochian Biosciences, Inc. (ENOB)October 13, 2022 | finance.yahoo.comFINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the FirmSeptember 26, 2022 | benzinga.comENOCHIAN DEADLINE ALERT: Bragar Eagel & Squire, P.C.September 24, 2022 | tmcnet.comEdelson Lechtzin LLP Reminds Enochian Biosciences, Inc. Investors of the Impending Lead Plaintiff DeadlineSeptember 23, 2022 | benzinga.comCLASS ACTION UPDATE for ENOB, MNSO and PLTR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 20, 2022 | benzinga.comSHAREHOLDER DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the FirmSeptember 19, 2022 | benzinga.comPre-market Movers: ATXG, FWBI, IDYA, ENOB, LUCY…September 16, 2022 | markets.businessinsider.comCLASS ACTION UPDATE for ENOB, MNSO and AZRE: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 15, 2022 | benzinga.comThe Gross Law Firm Announces Class Actions on...September 10, 2022 | benzinga.comCLASS ACTION UPDATE for ENOB, KRBP and LFST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 9, 2022 | benzinga.comEdelson Lechtzin LLP Notifies Enochian Biosciences, Inc. Investors of a Class Action LawsuitSeptember 9, 2022 | apnews.comThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ENOB, LFST and TSPSeptember 8, 2022 | barrons.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the FirmSeptember 7, 2022 | stockhouse.comCLASS ACTION UPDATE for MF, ENOB and TSP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 7, 2022 | benzinga.comThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ENOB, CVNA and LFSTSeptember 6, 2022 | benzinga.comCLASS ACTION UPDATE for MOLN, TGTX and ENOB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersSeptember 6, 2022 | benzinga.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Enochian Biosciences, Inc. with Losses of $100,000 to Contact the FirmSeptember 1, 2022 | stockhouse.com Remove Ads Get Enochian Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter. Email Address ENOB Media Mentions By Week ENOB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENOB News Sentiment▼0.000.62▲Average Medical News Sentiment ENOB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENOB Articles This Week▼00▲ENOB Articles Average Week Remove Ads Get Enochian Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENOB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DMAC News Today RAPT News Today LYEL News Today FULC News Today IVA News Today TNGX News Today PBYI News Today LXRX News Today PRQR News Today LRMR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENOB) was last updated on 4/5/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enochian Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enochian Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.